<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   2855
  </number>
  <updateDate>
   2023-01-11T13:48:34Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:48:34Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-04-26
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 71 (Monday, April 26, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. TONKO:H.R. 2855.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 1[Page H2115]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-04-27T17:46:46Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-26T16:00:11Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hswm00
    </systemCode>
    <name>
     Ways and Means Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hswm01
      </systemCode>
      <name>
       Social Security Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-04-26T18:31:55Z
        </date>
       </item>
      </activities>
     </item>
     <item>
      <systemCode>
       hswm02
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-04-26T18:31:33Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-26T16:00:16Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     Reduced Costs and Continued Cures Act
    </title>
    <congress>
     117
    </congress>
    <number>
     5260
    </number>
    <type>
     HR
    </type>
    <latestAction>
     <actionDate>
      2022-11-01
     </actionDate>
     <text>
      Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
   <item>
    <title>
     Reduced Costs and Continued Cures Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     5237
    </number>
    <type>
     HR
    </type>
    <latestAction>
     <actionDate>
      2022-11-01
     </actionDate>
     <text>
      Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-04-27
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-26
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hswm01
      </systemCode>
      <name>
       Social Security Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Social Security.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-26
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hswm02
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-26
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hswm00
      </systemCode>
      <name>
       Ways and Means Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-26
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-26
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-26
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     T000469
    </bioguideId>
    <fullName>
     Rep. Tonko, Paul [D-NY-20]
    </fullName>
    <firstName>
     Paul
    </firstName>
    <lastName>
     Tonko
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <district>
     20
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     G000563
    </bioguideId>
    <fullName>
     Rep. Gibbs, Bob [R-OH-7]
    </fullName>
    <firstName>
     Bob
    </firstName>
    <lastName>
     Gibbs
    </lastName>
    <party>
     R
    </party>
    <state>
     OH
    </state>
    <district>
     7
    </district>
    <sponsorshipDate>
     2021-04-26
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Health care costs and insurance
     </name>
    </item>
    <item>
     <name>
      Health care coverage and access
     </name>
    </item>
    <item>
     <name>
      Health care quality
     </name>
    </item>
    <item>
     <name>
      Health programs administration and funding
     </name>
    </item>
    <item>
     <name>
      Medicare
     </name>
    </item>
    <item>
     <name>
      Performance measurement
     </name>
    </item>
    <item>
     <name>
      Prescription drugs
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-04-26
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-06-23T13:34:00Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Star Rating for Biosimilars Act&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill requires the Centers for Medicare &amp;amp; Medicaid Services (CMS) to establish quality measures regarding biosimilar biological products under the five-star performance rating system for Medicare Advantage plans. The measures must assess the level of access that plans provide to covered biosimilars, including with respect to formularies, cost-sharing, and utilization management. &lt;/p&gt; &lt;p&gt;The CMS must also incorporate such measures into similar rating systems for plans under the Medicare prescription drug benefit.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Star Rating for Biosimilars Act
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Star Rating for Biosimilars Act
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to add a new set of measures to the 5-star rating system under the Medicare Advantage program in order to encourage increased access to biosimilar biological products.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Star Rating for Biosimilars Act
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-04-26T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr2855ih/xml/BILLS-117hr2855ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-04-27
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-04-27
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
2021-04-26
Social Security Subcommittee
hswm01
1
House committee actions
Referred to the Subcommittee on Social Security.
Committee
2021-04-26
Health Subcommittee
hswm02
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-26
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-04-26
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-04-26
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-26
9
Library of Congress
Introduced in House
IntroReferral
2021-04-26T16:00:11Z
Referred to
House
Energy and Commerce Committee
2021-04-27T17:46:46Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
2021-04-26T16:00:16Z
Referred to
House
Ways and Means Committee
2021-04-26T18:31:55Z
Referred to
Social Security Subcommittee
hswm01
2021-04-26T18:31:33Z
Referred to
Health Subcommittee
hswm02
hswm00
Standing
G000563
7
Bob
Rep. Gibbs, Bob [R-OH-7]
Gibbs
R
2021-04-26
OH
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-04-26
2021-04-27
Referred to the Subcommittee on Health.
House
Health
2022-11-01
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
CRS
Related bill
Reduced Costs and Continued Cures Act
HR
2022-11-01
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
CRS
Related bill
Reduced Costs and Continued Cures Act of 2021
HR
T000469
20
Paul
Rep. Tonko, Paul [D-NY-20]
N
Tonko
D
NY
Health care costs and insurance Health care coverage and access Health care quality Health programs administration and funding Medicare Performance measurement Prescription drugs
2021-04-26
Introduced in House
 <p><b>Star Rating for Biosimilars Act</b></p> <p>This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to establish quality measures regarding biosimilar biological products under the five-star performance rating system for Medicare Advantage plans. The measures must assess the level of access that plans provide to covered biosimilars, including with respect to formularies, cost-sharing, and utilization management. </p> <p>The CMS must also incorporate such measures into similar rating systems for plans under the Medicare prescription drug benefit.</p>
2021-06-23T13:34:00Z
00
2021-04-26T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr2855ih/xml/BILLS-117hr2855ih.xml
Star Rating for Biosimilars Act
Star Rating for Biosimilars Act
Display Title
IH
Introduced in House
To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to add a new set of measures to the 5-star rating system under the Medicare Advantage program in order to encourage increased access to biosimilar biological products.
Official Title as Introduced
IH
Introduced in House
Star Rating for Biosimilars Act
Short Title(s) as Introduced
HR
2023-01-11T13:48:34Z
2023-01-11T13:48:34Z
3.0.0
2022-11-01
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
CRS
Related bill
Reduced Costs and Continued Cures Act
HR
2022-11-01
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
CRS
Related bill
Reduced Costs and Continued Cures Act of 2021
HR
2021-04-27
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
2021-04-26
Social Security Subcommittee
hswm01
1
House committee actions
Referred to the Subcommittee on Social Security.
Committee
2021-04-26
Health Subcommittee
hswm02
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-26
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-04-26
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-04-26
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-26
9
Library of Congress
Introduced in House
IntroReferral
T000469
20
Paul
Rep. Tonko, Paul [D-NY-20]
N
Tonko
D
NY
G000563
7
Bob
Rep. Gibbs, Bob [R-OH-7]
Gibbs
R
2021-04-26
OH
Health care costs and insurance Health care coverage and access Health care quality Health programs administration and funding Medicare Performance measurement Prescription drugs
2021-04-26
Introduced in House
 <p><b>Star Rating for Biosimilars Act</b></p> <p>This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to establish quality measures regarding biosimilar biological products under the five-star performance rating system for Medicare Advantage plans. The measures must assess the level of access that plans provide to covered biosimilars, including with respect to formularies, cost-sharing, and utilization management. </p> <p>The CMS must also incorporate such measures into similar rating systems for plans under the Medicare prescription drug benefit.</p>
2021-06-23T13:34:00Z
00
Star Rating for Biosimilars Act
Star Rating for Biosimilars Act
Display Title
IH
Introduced in House
To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to add a new set of measures to the 5-star rating system under the Medicare Advantage program in order to encourage increased access to biosimilar biological products.
Official Title as Introduced
IH
Introduced in House
Star Rating for Biosimilars Act
Short Title(s) as Introduced
2021-04-27
Referred to the Subcommittee on Health.